Andere Sprachen Lavipharm S.A.

Aktien

Verzögert Athens S.E. Andere Börsenplätze 10:54:16 15.05.2024			% 5 Tage	% 1. Jan.
0,95 ^EUR	+6,15 %		+10,70 %	+19,60 %

28.02.	Lavipharm S.A. meldet Ergebnis für das Geschäftsjahr zum 31. Dezember 2023	CI
2023	Lavipharm S.A. meldet Ergebnis für die neun Monate bis zum 30. September 2023	CI

Lavipharm S A : Annual Analysts Briefing	24.04.
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	28.02.
Lavipharm S A : ANNOUNCEMENT	11.12.
Lavipharm S A : enters into a new asset purchase agreement	11.12.
Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	11.12.
Lavipharm S A : Asset Purchase Agreement for Lavipharm	01.12.
Lavipharm S.A. signing of an asset purchase agreement to acquire Lonarid N and Lonalgal from Boehringer Ingelheim International GmbH.	01.12.
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	08.11.
Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	21.09.23
Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	21.09.23
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	21.09.23
Lavipharm S A : Annual Shareholders’ Meeting	06.07.23
Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	06.07.23
Lavipharm S.A.(ATSE:LAVI) added to ATHEX Composite Index	21.06.23
Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	26.05.23
Lavipharm S A : Results Q1 2023	04.05.23
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	04.05.23
Lavipharm S A : AMENDMENT OF THE 2023 FINANCIAL CALENDAR	27.04.23
Lavipharm S A : ANNOUNCEMENT	28.03.23
Lavipharm S A : Announcement 1668/2023	15.03.23

Keine Ergebnisse zu dieser Suche